SLC7A11 and cancer: The knockdown of xCT by siRNA and supplementation with the xCT inhibitor, sulfasalazine [29], significantly attenuated the glucose deprivation-induced cell death in cancer cells with or without salubrinal treatment in MDA-MB-231, AGS, and SAS cell lines (Figure 4B,C).